tiprankstipranks
Replimune Group (REPL)
NASDAQ:REPL

Compare Replimune Group (REPL) vs. Competitors

500 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Replimune Group
$1.70
$393.05M
-74.03%
0 Buy
4 Hold
3 Sell
Moderate Sell
Anavex Life Sciences
$3.11
$288.21M
-13.95
-64.63%
1 Buy
0 Hold
0 Sell
Moderate Buy
Arcus Biosciences
$22.39
$2.81B
-7.25
199.61%
7 Buy
2 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$10.40
$1.04B
-5.55
106.07%
10 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$15.91
$1.65B
-5.04
65.48%
11 Buy
0 Hold
0 Sell
Strong Buy
Sana Biotechnology
$3.21
$856.64M
-4.22
92.27%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
REPL
Replimune Group
1.95
-5.76
-74.71%
AVXL
Anavex Life Sciences
3.12
-6.00
-65.79%
RCUS
Arcus Biosciences
23.01
15.00
187.27%
ORIC
Oric Pharmaceuticals
10.53
5.49
108.93%
NRIX
Nurix Therapeutics
16.30
6.48
65.99%
SANA
Sana Biotechnology
3.48
1.78
104.71%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts